Physician Advisory Board
Our Physician Advisory Board provides general oversight and guidance on our approach to providing essential information to practicing clinicians.
Each adviser provides specific guidance and commentary for Univadis in his or her area of medical expertise.
Christopher Cannon is a cardiologist at Brigham and Women’s Hospital and currently serves as Executive Director of Cardiometabolic Trials at the Harvard Clinical Research Institute (HCRI). For 25 years, Dr. Cannon has been a member of the Thrombolysis in Myocardial Infarction (TIMI) Study Group. He has been principal investigator of more than 15 multicenter clinical trials including TACTICS-TIMI 18, PROVE IT-TIMI 22, and IMPROVE IT. Dr. Cannon’s research has focused on management and prevention of acute coronary syndromes (ACS) with a goal of trying to directly improve patient care. Collaborating with others, he has helped establish various antithrombotic and interventional strategies for ACS, as well as long-term lipid management approaches for prevention. More recently, he has become involved in studying prevention approaches in diabetes and in atrial fibrillation. Finally, Dr. Cannon helps lead registries with an aim toward implementation of research advances in clinical practice.
Alex Denes is Associate Professor of Medicine, Hematology, and Medical Oncology at the Knight Cancer Institute at Oregon Health Science University, where he focuses on breast cancer. Dr. Denes previously worked as Associate Professor at the Washington University School of Medicine in St. Louis, and served as Director of the School of Medicine’s inpatient oncology service.
Dr. Fonseca is Professor of Medicine, the Tullis–Tulane Alumni Chair in Diabetes, and chief of the Section of Endocrinology at Tulane University Medical Center in New Orleans, Louisiana. He currently serves on the Board of Directors of the American Association of Clinical Endocrinologists (AACE), and the Board of Trustees of the American College of Endocrinology. He is a Past President for Science and Medicine of the American Diabetes Association (2012), and has held a leadership role and served on various committees in several other organizations including the American Diabetes Association, the American College of Endocrinology and the American Board of Internal Medicine. He is Editor in Chief of the Journal of Diabetes and its Complications. He was Editor in chief of Diabetes Care from 2007-2011, having formerly been associate editor. He was until 2006 Editor in Chief of the Journal of the Metabolic Syndrome and related disorders. He served on the editorial board of the Journal of Clinical Endocrinology and Metabolism (2003-2006), and is an ad hoc reviewer for several other journals, including New England Journal of Medicine, JAMA, Diabetes, etc.
Dr. Fonseca is a fellow of the American Association of Clinical Endocrinologists, the Royal College of Physicians (London), and the American College of Physicians. Dr. Fonseca has served on and been chairman of the clinical practice committee of the American Diabetes Association, the ADA Disaster Task Force, ADA strategic planning committee and the joint ADA/ACC "Make the Link" Program. He has played a significant role in developing guidelines for treating diabetes, managing chronic disease and clinical trials after a natural disaster and in drawing attention to the global epidemic of diabetes, particularly in Asia. The American Diabetes Association awarded him the ADA Banting Medal for Leadership and Service and the Southern Medical Association awarded him the Seale – Harris award. He has received several teaching awards and was elected to the Alpha Omega Alpha Honor Medical Society and has been listed among the Best Doctors in the USA, LA and AR.
Dr. Kalhan is Director of the Northwestern Asthma and Chronic Obstructive Pulmonary Disease (COPD) Program where comprehensive care is provided to patients with asthma and COPD at all stages of severity. Dr. Kalhan additionally serves as director of the Alpha-1-Antitrypsin Deficiency Clinical Resource Center at Northwestern and medical director of the lung volume reduction surgery (LVRS) program. Dr. Kalhan attended college at Brown University in Providence, RI where he majored in modern American history. He subsequently entered medical school at Case Western Reserve University School of Medicine and completed his internal medicine residency at the Hospital of the University of Pennsylvania. He then came to Chicago where he pursued his fellowship training in Pulmonary and Critical Care Medicine at Northwestern Memorial Hospital, and has been on the Northwestern faculty since 2006. Dr. Kalhan's clinical interests are in the care of patients with both asthma and COPD as well as alpha-1-antitrypsin deficiency. His research interests relate to respiratory epidemiology, in particular identification of early risk factors that impact the vulnerability of certain cigarette smokers to develop COPD. He is also involved in clinical trials of new therapies for both asthma and COPD. Dr. Kalhan additionally serves as Chairman of the Illinois COPD Coalition a multidisciplinary group including representatives from community-based organizations, public health departments, professional organizations, patients, caregivers, healthcare providers, pharmaceutical companies and home healthcare providers which has the goal of implementing sustainable solutions for reducing the burden of COPD in Illinois.
Daniel Kantor, MD, FAAN is the President of the Medical Partnership 4 MS (MP4MS), the largest advocacy group for neurologist treating patients with MS. He is the Past President of the Florida Society of Neurology, former Director of the Comprehensive MS Center at University of Florida - Jacksonville and Past Chair of FL Medicaid Pharmacy & Therapeutics Committee. He is an active member of the medical advisory boards of the Multiple Sclerosis Foundation (MSF), Multiple Sclerosis Association of America (MSAA) and MS Views and News. Dr. Kantor is Past Chair of Education and Board Member of the Southern Headache Society. Dr. Kantor is the Chief Medical Correspondent for MSWorld and the Chair of the Subcommittee on Concussion for the Sports Medicine Advisory Board of the Florida High School Athletics Association. He practices neurology in South Florida.
Dr. Lee is a board-certified dermatologist who further sub-specialized by completing a fellowship in Mohs Micrographic Surgery/Skin Cancer/Facial Plastic Reconstruction, Laser Surgery, Cosmetic Surgery, and Advanced Dermatologic Surgery from University of California, San Francisco. She is founder and director of The Skin and Laser Treatment Institute (started in 2015) and The East Bay Laser & Skin Care Center (started in 1999), both in Walnut Creek, CA. She is also an Assistant Clinical Professor in the Department of Dermatologic Surgery at the University of California, San Francisco. She is an internationally recognized pioneer in the field of laser cosmetic surgery and is a research adviser and consultant to the laser and cosmetic industry. Through her own research, Dr. Lee has developed techniques that have greatly improved the effectiveness and results of laser treatments. She has lectured to physicians all around the world and been involved with the training of thousands of physicians. She has published numerous scientific papers and articles in addition to being the author of "The Ultimate Guide for the Best Skin Ever: Lasers".
Dr.Temte received his BA in biology from Luther College, (Decorah, Iowa) in 1980. He received an MS in biological oceanography from Oregon State University in 1986 and a PhD in zoology (minor: epidemiology) from the University of Wisconsin in 1993. His MS and PhD work centered on photoperiodism and birth timing of seals and sea lions.
Dr. Temte pursued his medical training at the UW-Madison Medical School receiving his MD in 1987. He is a 1993 graduate of the University of Wisconsin - Madison Family Practice Residency where he stayed on as a faculty, achieving the rank of Professor. He teaches family practice residents and practices full-spectrum primary care medicine to an under-served and highly diverse community at Wingra Family Medical Center in Madison, Wisconsin.
Dr. Temte just completed his tenure as chair of the U.S. Advisory Committee on Immunization Practices (ACIP). He represented the American Academy of Family Physicians (AAFP) at the CDC Measles Elimination Meeting in 2000 and the Rubella Elimination Meeting in 2004. He chaired the AAFP Commission on Science in 2008 and currently chairs the Wisconsin Council on Immunization Practices. He served as AAFP liaison to the ACIP from 2004-2008, was appointed to a four-year term as a voting member of ACIP (2008-2011), and was re-appointed for an addition four-year term, through June, 2015. He is the first family physician to have served as chair. During his tenure at ACIP, Jon has chaired working Groups on MMRV Safety, Evidence-based Recommendations, and MMR Vaccine. Jon has participated on pandemic influenza and bioterrorism working groups for the state of Wisconsin. He is the principal investigator of the Wisconsin Influenza Incidence Surveillance Project, the Oregon Child Absenteeism due to Respiratory Disease Study, and the Real-Time Surveillance of Influenza in Ambulatory Primary Care Program.